LG Life Sciences clinical trials

Acquired by LG Chem, Jan 1, 2017 · source ↗

The registry lists 78 studies whose lead sponsor is LG Life Sciences. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 15, 2021.

Studies

Recruiting first, then most recently updated. Showing 50 of 78. List all 78 → · All LG Chem studies →

• A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT02746380Phase 3

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Clinical Study to Evaluate the Correction of Wrinkles and Folds and Safety of YVOIRE Classic Versus Restylane in Nasolabial Fold Intradermal InjectionCompletedNCT03738020Not applicable

  Sponsor listed in the registry: LG Life Sciences · First submitted after LG Life Sciences became part of LG Chem

• To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran®CompletedNCT03051087Phase 4

  Sponsor listed in the registry: LG Life Sciences · First submitted after LG Life Sciences became part of LG Chem

• Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi SyndromeCompletedNCT02204163Phase 3

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Volume sCompletedNCT02661737

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic sCompletedNCT02334358

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With GemigliptinCompletedNCT02290301

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• A Clinical Study to Evaluate the Efficacy and Safety of YVOIRE Classic Plus Versus YVOIRE Classic in Nasolabial Fold InjectionCompletedNCT02340091Not applicable

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• A Clinical Study to Evaluate the Efficacy and Safety of YVOIRE Volume Plus Versus YVOIRE Volume in Nasolabial Fold InjectionCompletedNCT02340078Not applicable

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.CompletedNCT03015909Phase 4

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Clinical Study to Evaluate the Correction of Facial Wrinkles and Folds and Safety of YVOIRE Volume Versus Perlane in Nasolabial Fold InjectionCompletedNCT03738007Not applicable

  Sponsor listed in the registry: LG Life Sciences · First submitted after LG Life Sciences became part of LG Chem

• Extension Clinical Study to Evaluate the Long-term Efficacy and Safety of Repeat Treatment of YVOIRE Contour Injected Into the Anteromedial Malar Region in Subjects Who Have Completed the LG-HACL014 StudyCompletedNCT02119793Not applicable

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Study of LC23-1306 in Healthy Male SubjectsCompletedNCT01526577Phase 1

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• A Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active RA Despite Methotrexate (MTX)CompletedNCT02715908Phase 3

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)CompletedNCT02831361Phase 3

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in AdultsCompletedNCT02892812Phase 1

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)CompletedNCT02126358Phase 3

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI PatientsStatus unknownNCT02770664Phase 2

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• BE Study of the Combinations of Gemigliptin 50mg and Rosuvastatin 20mg in Comparison to Each Component Administered AloneStatus unknownNCT02670070Phase 1

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Phase 2 Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI PatientsCompletedNCT02070471Phase 2

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension PatientsStatus unknownNCT02415192

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and MetforminCompletedNCT01990469Phase 3

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Efficacy and Safety Study of Sr-hGH in Comparison With Daily hGH in ISS PatientsCompletedNCT02042170Phase 2

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• A Phase IIIb Study to Evaluate the Safety and Efficacy of Gemigliptin in Type 2 Diabetes Mellitus Patients With Moderate or Severe Renal Impairment(GUARD Study)CompletedNCT01968044Phase 3

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Bioequivalence of a Single Subcutaneous Dose of BEPO and REPO in Healthy Male SubjectsCompletedNCT02426151Phase 1

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• To Assess the Anti-adhesive Effect and Safety of ProtescalTerminatedNCT01810900Phase 3

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of IVF-M HP Inj. vs. Menopur® Inj.CompletedNCT02458768Phase 4

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Each Component Administered AloneStatus unknownNCT02670018Phase 1

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate TherapyStatus unknownNCT02357069Phase 3

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Clinical Study to Evaluate the Efficacy and Safety of YVOIRE® Contour Compared With Restylane SubQ™ Injected Into the Anteromedial Malar RegionStatus unknownNCT02119780Not applicable

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• A Clinical Trial to Evaluate the Safety and Efficacy of Retreatment With Intra-articular LBSA0103 Injections in the Patients With Osteoarthritis of the KneeCompletedNCT02122601Phase 3

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Pharmacokinetics and Safety Study of LBAL in Healthy SubjectsCompletedNCT02206867Phase 1

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Pharmacokinetics and Safety Study of Apetrol ESCompletedNCT02446353Phase 1

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered AloneCompletedNCT01662674Phase 1

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.dCompletedNCT01787396Phase 3

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)CompletedNCT01890629Phase 4

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 500mg in Comparison to Each Component Administered AloneCompletedNCT01595880Phase 1

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25mg With Those of Enbrel®CompletedNCT01725620Phase 1

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male SubjectsCompletedNCT01825850Phase 1

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and HyperlipidemiaCompletedNCT01918332Phase 3

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 WeeksStatus unknownNCT02257645

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Influence of Hepatic Impairment on Pharmacokinetic (PK) and Pharmacodynamic (PD) of Gemigliptin PK and PD After Multiple Oral Doses in Healthy White VolunteersCompletedNCT02004587Phase 1

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone.CompletedNCT02056600Phase 1

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 DiabetesStatus unknownNCT02089126Phase 3

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Study to Investigate the Safety and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male SubjectsCompletedNCT01737424Phase 1

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Food-Effect Bioavailability Study of FDC(Gemigliptin/Metformin HCl Sustained Release) 50/1000mg(25/500mg x 2tablets)CompletedNCT01747083Phase 1

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive PatientsCompletedNCT01928628Phase 3

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Study for Investigate the Pharmacokinetic Drug Interactions Between Gemigliptin and RosuvastatinCompletedNCT01823133Phase 1

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male VolunteersCompletedNCT01918709Phase 1

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem

• Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mgCompletedNCT01918358Phase 1

  Sponsor listed in the registry: LG Life Sciences · First submitted before LG Life Sciences became part of LG Chem